临床试验中的因果调解框架,用于理解和沟通临床试验中的估计和分析策略
1Keros Therapeutics, 1050 Waltham St, Suite 302 Lexington, MA 02421, USA.
Contemporary clinical trials
|July 20, 2025
概括
临床试验中的估计是复杂的,但像DAG这样的因果推理工具可以澄清它们的含义. 因果调解框架有助于为间流事件选择适当的分析策略,改善利益相关者之间的沟通.
科学领域:
- 临床试验方法论 临床试验方法论
- 因果推理因果推理
- 生物统计学 生物统计学
背景情况:
- 在ICH E9 (R1) 附录中引入的估计是临床试验设计的组成部分,植根于因果推理原则.
- 广泛实施和利益相关者参与正在进行中,但明确沟通估计仍然是一个挑战.
- 导向循环图 (DAG) 和单一世界干预图 (SWIG) 等因果推断工具有助于定义和传达估计值.
研究的目的:
- 为应对在临床试验中向各种利益相关者沟通估计的挑战.
- 为了澄清处理效应的类型,估计和目标是在处理间流事件时捕获.
- 提供精简的决策工作流程,以选择适当的评估和评估分析策略.
主要方法:
- 使用因果推理框架,包括反事实结果,DAG和SWIG,用于定义和传达估计值.
- 应用因果调解框架,将估计值与特定类型的治疗效果联系起来.
- 开发了一个决策工作流程,以指导选择分析策略,以处理在估计中的间流事件.
主要成果:
- 证明了因果推理工具在增强估计者的定义,识别和沟通方面的宝贵作用.
- 建立了估计值与估计效应类型之间的明确联系,特别是在涉及间流事件的情况下.
- 根据因果调解框架,提出了一种选择适当分析策略的实际工作流程.
结论:
- 因果调解框架提供了一种结构化的方法,用于理解和选择涉及间流事件的估计分析.
- 通过这些因果推理方法,可以在功能利益相关者之间更好地理解和沟通估计值.
- 促进更有效的临床试验设计和解释,通过澄清在存在间流动事件时对治疗效果的估计.
更多相关视频
10:26Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
Published on: September 11, 2021
4.1K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
177
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
177
01:25Strategies for Assessing and Addressing Confounding
156
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
156
01:21Causality in Epidemiology
863
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
863
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:24Kaplan-Meier Approach
272
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
272
01:20Comparing the Survival Analysis of Two or More Groups
291
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
291